Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
13%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
PBPH
57
HOLDINGS
20%
ALSO IN XPH
XPH
57
HOLDINGS
17%
ALSO IN PBPH
SECTOR DRIFT (PBPH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.9% | 2.5% | 2.5% |
|
PFIZER INC | 3.4% | 2.2% | 2.2% |
|
JOHNSON & JOHNSON | 9.3% | 2.0% | 2.0% |
|
MERCK & CO. INC. | 5.2% | 2.0% | 2.0% |
|
BRISTOL-MYERS SQUIBB CO | 2.5% | 1.9% | 1.9% |
PBPH Overweight Relative to XPH
|
ELI LILLY & CO | 14.4% |
|
ABBVIE INC | 7.4% |
|
JOHNSON & JOHNSON | 7.3% |
 |
ASTRAZENECA PLC | 4.8% |
|
AMGEN INC | 4.4% |
 |
NOVARTIS AG | 4.2% |
|
GILEAD SCIENCES INC | 4.1% |
|
MERCK & CO. INC. | 3.2% |
|
VERTEX PHARMACEUTICALS INC | 2.7% |
 |
NOVO NORDISK A/S-B | 2.5% |
PBPH Underweight Relative to XPH
|
VERADERMICS INC | -2.8% |
|
PACIRA PHARMACEUTICALS INC | -2.5% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.5% |
|
MAZE THERAPEUTICS INC | -2.3% |
|
LIGAND PHARMACEUTICALS-CL B | -2.2% |
 |
PERRIGO CO | -2.2% |
|
SEPTERNA INC | -2.2% |
|
BIOSANTE PHARMACEUTICALS INC | -2.0% |
|
ORGANON & CO. | -2.0% |
|
PRESTIGE BRANDS HOLDINGS INC | -2.0% |